Multiple Assemblies exist for SMTL entry 5ij8
Structure of the primary oncogenic mutant Y641N Hs/AcPRC2 in complex with a pyridone inhibitor; X-RAY DIFFRACTION 2.99 Å

	SMTL ID 5ij8.1 Ligands 5,8-dichloro-2-[(4-ethyl-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-7-({1-[(2R)-2-hydroxypropanoyl]piperidin-4-yl}oxy)-3,4-dihydroisoquinolin-1(2H)-one; ZINC ION Polypeptides Enhancer of Zeste Homolog 2 (EZH2),Histone-lysine N-methyltransferase EZH2; Polycomb protein EED; Polycomb protein SUZ12 Oligo-state hetero-1-1-1-mer
	SMTL ID 5ij8.2 Ligands 5,8-dichloro-2-[(4-ethyl-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-7-({1-[(2R)-2-hydroxypropanoyl]piperidin-4-yl}oxy)-3,4-dihydroisoquinolin-1(2H)-one; ZINC ION Polypeptides Enhancer of Zeste Homolog 2 (EZH2),Histone-lysine N-methyltransferase EZH2; Polycomb protein EED; Polycomb protein SUZ12 Oligo-state hetero-1-1-1-mer